
-
2005
Company Description
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.
-
Manufacturer:
Science and Engineering -
Formed:
2005 -
Founders:
Robert E. Desjardins -
Company Website:
-
Company E-mail:
-
Company Address:
Mack Centre IV, 4th FloorParamus, NJUnited States -
CEO:
- Robert E. Desjardins
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits